CROs can contribute to site collaboration by also identifying and supporting non-academic institutions capable of conducting ...

As the industry prioritises health equity and inclusion in clinical research ... get-go will be the key to opening the treasure box of tangible benefits of DCTs for all stakeholders.

Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key ...

CTI grew from a Cincinnati startup to a global leader in clinical research. CEO Tim Schroder shares insights on its success ...

One of the key themes of the WHO guidance is ensuring ... The paper discusses the need for harmonisation between stakeholders in clinical trials to try and improve accessibility to research ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving ...